IL17A

interleukin 17A, the group of Interleukins

Basic information

Region (hg38): 6:52186375-52190638

Previous symbols: [ "CTLA8", "IL17" ]

Links

ENSG00000112115NCBI:3605OMIM:603149HGNC:5981Uniprot:Q16552AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IL17A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL17A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
11
clinvar
11
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
4
clinvar
4
Total 0 0 11 0 5

Variants in IL17A

This is a list of pathogenic ClinVar variants found in the IL17A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-52186457-T-C not specified Uncertain significance (Jan 16, 2024)3109126
6-52186476-G-A not specified Benign (Jan 24, 2024)1273159
6-52187660-C-G not specified Uncertain significance (Nov 17, 2023)3109127
6-52187713-G-A not specified Uncertain significance (Dec 28, 2023)3109124
6-52187718-A-T not specified Uncertain significance (May 03, 2023)2543405
6-52187769-A-G not specified Uncertain significance (Mar 31, 2024)3285756
6-52187781-G-A not specified Uncertain significance (Dec 17, 2023)3109125
6-52188798-T-C Benign (Jun 19, 2021)1178355
6-52189060-A-G not specified Uncertain significance (Jun 13, 2022)2391973
6-52189095-G-A not specified Uncertain significance (Sep 06, 2022)2361732
6-52189097-G-T not specified Uncertain significance (Feb 15, 2023)2485402
6-52189126-A-T not specified Uncertain significance (May 31, 2023)2553500
6-52189179-A-G not specified Uncertain significance (Sep 17, 2021)2251932
6-52189226-G-A Benign (Jun 27, 2018)771398
6-52189240-T-C not specified Uncertain significance (Apr 05, 2023)2514849
6-52189451-G-A Benign (Jun 19, 2021)1266947
6-52190541-C-T Benign (Feb 18, 2020)1270340

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IL17Aprotein_codingprotein_codingENST00000340057 34252
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.04300.8571257020181257200.0000716
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2758592.40.9190.00000544998
Missense in Polyphen1626.2680.6091285
Synonymous-1.514836.41.320.00000194324
Loss of Function1.3536.780.4424.72e-767

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009040.0000904
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0003230.000323
European (Non-Finnish)0.00006180.0000616
Middle Eastern0.000.00
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Ligand for IL17RA and IL17RC (PubMed:17911633). The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC (PubMed:18684971). Involved in inducing stromal cells to produce proinflammatory and hematopoietic cytokines (PubMed:8676080). {ECO:0000269|PubMed:17911633, ECO:0000269|PubMed:18684971, ECO:0000269|PubMed:8676080}.;
Pathway
Inflammatory bowel disease (IBD) - Homo sapiens (human);Th17 cell differentiation - Homo sapiens (human);IL-17 signaling pathway - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);IL17 signaling pathway;Allograft Rejection;Development and heterogeneity of the ILC family;Interleukin-4 and 13 signaling;T-Cell antigen Receptor (TCR) Signaling Pathway;JAK STAT MolecularVariation 1;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;JAK STAT pathway and regulation;GPCR signaling-G alpha i;IL23-mediated signaling events;IL27-mediated signaling events (Consensus)

Recessive Scores

pRec
0.740

Intolerance Scores

loftool
0.309
rvis_EVS
-0.19
rvis_percentile_EVS
39.68

Haploinsufficiency Scores

pHI
0.141
hipred
N
hipred_score
0.112
ghis
0.478

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.514

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Il17a
Phenotype
digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype; hematopoietic system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
apoptotic process;inflammatory response;immune response;cell-cell signaling;cell death;regulation of signaling receptor activity;cytokine-mediated signaling pathway;positive regulation of interleukin-23 production;positive regulation of osteoclast differentiation;positive regulation of transcription by RNA polymerase II;fibroblast activation;interleukin-17-mediated signaling pathway
Cellular component
extracellular region;extracellular space
Molecular function
cytokine activity;protein binding